SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,668,055 | -47.0% | 700,863 | +6.7% | 0.00% | -100.0% |
| Q2 2023 | $3,146,043 | +73.0% | 656,794 | +104.8% | 0.00% | – |
| Q1 2023 | $1,818,641 | -2.9% | 320,748 | -4.1% | 0.00% | – |
| Q4 2022 | $1,872,601 | +9.8% | 334,393 | +25.9% | 0.00% | – |
| Q3 2022 | $1,705,000 | -13.1% | 265,531 | -53.5% | 0.00% | – |
| Q2 2022 | $1,962,000 | -62.2% | 571,548 | -21.5% | 0.00% | -100.0% |
| Q1 2022 | $5,187,000 | -49.7% | 728,549 | -41.2% | 0.00% | -50.0% |
| Q4 2021 | $10,316,000 | +159.4% | 1,238,450 | +116.7% | 0.00% | +100.0% |
| Q3 2021 | $3,977,000 | -76.9% | 571,515 | -20.9% | 0.00% | -75.0% |
| Q2 2021 | $17,232,000 | -7.9% | 722,509 | -20.5% | 0.00% | -20.0% |
| Q1 2021 | $18,719,000 | +2.6% | 909,120 | +22.1% | 0.01% | 0.0% |
| Q4 2020 | $18,243,000 | +10.8% | 744,615 | +28.0% | 0.01% | 0.0% |
| Q3 2020 | $16,465,000 | +844.1% | 581,608 | +58.7% | 0.01% | +400.0% |
| Q2 2020 | $1,744,000 | +193.6% | 366,409 | +120.0% | 0.00% | – |
| Q1 2020 | $594,000 | +5.1% | 166,573 | +1.7% | 0.00% | – |
| Q4 2019 | $565,000 | +23.1% | 163,856 | +43.3% | 0.00% | – |
| Q3 2019 | $459,000 | -77.3% | 114,349 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $2,021,000 | +172.0% | 627,596 | +480.5% | 0.00% | – |
| Q1 2019 | $743,000 | +137.4% | 108,117 | +56.1% | 0.00% | – |
| Q4 2018 | $313,000 | -48.9% | 69,242 | -14.3% | 0.00% | – |
| Q3 2018 | $613,000 | -1.3% | 80,796 | +11.8% | 0.00% | – |
| Q2 2018 | $621,000 | +109.1% | 72,241 | +78.2% | 0.00% | – |
| Q1 2018 | $297,000 | -40.8% | 40,529 | -18.2% | 0.00% | – |
| Q4 2017 | $502,000 | +9.1% | 49,530 | +72.6% | 0.00% | – |
| Q3 2017 | $460,000 | +74.9% | 28,691 | +23.1% | 0.00% | – |
| Q2 2017 | $263,000 | -47.5% | 23,315 | -47.5% | 0.00% | – |
| Q1 2017 | $501,000 | +42.3% | 44,418 | +24.9% | 0.00% | – |
| Q4 2016 | $352,000 | +44.3% | 35,567 | +79.1% | 0.00% | – |
| Q3 2016 | $244,000 | -42.5% | 19,863 | +36.1% | 0.00% | – |
| Q2 2016 | $424,000 | -87.5% | 14,597 | -88.6% | 0.00% | -100.0% |
| Q1 2016 | $3,390,000 | +6.0% | 127,604 | +40.0% | 0.00% | – |
| Q4 2015 | $3,197,000 | +97.7% | 91,129 | +67.1% | 0.00% | – |
| Q3 2015 | $1,617,000 | – | 54,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |